The ASHG 2020 virtual meeting includes 18 Invited sessions programmed across four days of programming (October 27-30). All sessions are included in the registration fee and will be available on demand afterwards.

Invited sessions are developed and proposed by ASHG members around a particular topic of interest and run in concurrent timeslots. Submitting an invited proposal offers ASHG members the opportunity to directly participate in the development of the scientific program. Through a rigorous review process, the ASHG Program Committee assembles the best program possible on a diverse set of topics in human genetics.

Invited speaker guidelines and presentation instructions will be available shortly at this link.

Invited Sessions 2020; all descriptions are available now.

Tuesday

• Design, Development, and Implementation of Large-Scale Clinical Pharmacogenomics: Provider, Payer and Researcher Perspectives
• Solving for X: The Hidden Roles of the Sex Chromosomes in Development, Disease and Evolution
• Big Data and Bioethics
• Delivering Genomics Digitally: Are We Ready?

Wednesday

• ASHG/ESHG Building Bridges Symposium: Reconciling U.S. and European Guidelines on Variant Interpretation and Secondary Findings
• Variant-to-Function Coupling: Understanding Non-coding Variation in Human Disease
• Re-Evaluating Penetrance: Modifiers, Mechanisms and Implications for Genetic Testing
• Asthma in Diverse Populations
• Underrepresented Populations in Genomics: Health, Evolutionary, and Ethical Aspects

Thursday

• The History and Future of Protections Against Genetic Discrimination
• Scalable Functional Genomics Approaches to Dissect Genetic Architecture
• Extending Phenotype-Genotype Correlations to the Fetus: Integrating Genetics, Imaging, and the Electronic Health Record
• Evolutionary Genomic Medicine

Friday

• Application of Long Read Methods to Cancer Genomics
• Indigenous Biobanking: Global Perspectives on Keeping Our Genomic Data Local
• Advances in Functional Transcriptomics: Linking Genetic Variation tRNA Processing
• Epi-Phenotyping of Neurodevelopmental Disabilities
• Using Novel Analytical Approaches to Identify High-Risk Genes in Next-Generation Sequencing of Multiplex Pedigrees